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Pain in fibromyalgia (FM) is accompanied by a heterogeneous series of other symptoms,
which strongly affect patients’ quality of life and interfere with social and work
performance. The present study aimed to evaluate the effects of alexithymia on both the
physical and the psychosocial components of the health-related quality of life (HRQoL)
of FM patients, controlling for the concomitant effects of depression, anxiety, and pain.
In particular, given the strong interconnection between depression and alexithymia, the
relationship between alexithymia and HRQoL as mediated by depressive symptoms
was further investigated. Data were collected on a consecutive sample of 205 female
patients with a main diagnosis of FM. The results showed that about 26% of the patients
showed the presence of alexithymia, as assessed by the Toronto Alexithymia Scale
(TAS-20). Clinically relevant levels of depressive and anxiety symptoms were present
in 61 and 60% of the patients, respectively. The results of the hierarchical multiple
regression analyses showed that pain intensity (PI) and depressive symptoms explained
the 45% of the variance of the physical component of HRQoL (p < 0.001). Regarding
the mental component of HRQoL, depressive and anxiety symptoms, alexithymia, and
PI significantly explained 61% of the variance (p < 0.001). The mediation analyses
confirmed that alexithymia had a direct effect on the mental component of HRQoL and
showed a statistically significant indirect effect on both the physical and the mental
components, through the mediation of depressive symptoms. In conclusion, the results
of the present study suggested the presence of both a direct and an indirect effect of
alexithymia, in particular of the difficulty identifying feeling, on the HRQoL of patients
with FM. Indeed, even though the concomitant presence of depressive symptoms is
responsible of an indirect effect, alexithymia per se seems to directly contribute to
worsen the impact that this chronic pain pathology has on the patients’ quality of life,
especially regarding the psychosocial functioning.
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INTRODUCTION
Fibromyalgia (FM) is characterized by widespread
musculoskeletal pain, with palpation-specific regions of
tenderness, associated with other symptoms, such as fatigue,
non-restorative sleep, mood disorders, and cognitive impairment
(Mease, 2005; Wolfe et al., 2010). This chronic pain syndrome
has a complex and multifactorial etiopathogenesis and it affects
mainly women (Williams and Gracely, 2007). Its prevalence
ranges between 3 and 6% of the world population (World
Health Organization (WHO), 2008), even though a recent
literature review update showed a significant increase in FM
prevalence worldwide (Marques et al., 2017). The heterogeneous
series of physical and psychological symptoms experienced
by FM patients has a negative impact on patients’ functioning
and quality of life, strongly interfering with social and work
performance (Sturge-Jacobs, 2002; Arnold et al., 2008). Among
the psychological ones, depressive and anxiety symptoms have
been widely reported, with prevalence ranging between 20 and
80% for depressive and between 13 and 64% for anxiety disorders
(Bradley, 2005; Fietta et al., 2007).
Another psychological factor that has recently attracted the
attention is alexithymia, a multifaceted personality dimension,
largely observed in “psychosomatic” disorders (Taylor, 2000).
Alexithymia has been related with several psychiatric and
medical disorders, including chronic pain and FM (Lumley
et al., 1997, 2002; Taylor et al., 1999; Celikel and Saatcioglu,
2006; van Leeuwen et al., 2012; Di Tella and Castelli, 2016).
Alexithymia is characterized by a reduced ability to identify and
describe subjective feelings, difficulty in distinguishing between
feelings and bodily sensations of emotional arousal, restricted
imagination processes, and a stimulus-bound, externally oriented
cognitive style (Sifneos, 1973; Taylor et al., 1999). These deficits
could interfere with the cognitive processing and regulation of
emotions, resulting in increased negative affects (Martínez et al.,
2015) and dysregulation of stress-related autonomic arousal, with
chronic sympathetic hyperarousal (Lumley et al., 1996; Taylor
and Bagby, 2012). In their study, indeed, Martínez et al. (2015)
found that the difficulties in identifying their affective states, in
interaction with negative pain appraisal (i.e., pain catastrophizing
and fear of pain), could lead FM patients to develop emotional
distress (in particular anxiety). Moreover, alexithymia can affect
health perception, leading alexithymic subjects to misinterpret
the bodily expressions of emotions as signs of physical disease
and thus worsening the patients’ quality of life and enhancing
the health care utilization (Lumley et al., 1996, 2007; Tuzer et al.,
2011). Even though several studies have identified alexithymia as
an important factor in FM syndrome (Sayar et al., 2004; Steinweg
et al., 2011; Castelli et al., 2012; Di Tella et al., 2017; Ghiggia
et al., 2017), the association between alexithymia and FM patients’
quality of life is not clear yet. The few evidences available suggest
a possible role of negative affects, particularly depression, in
mediating this relationship (Castelli et al., 2012). However, to the
best of our knowledge, no study has deeply investigated yet the
association between alexithymia and quality of life in FM patients.
The present study aimed thus to evaluate the effects
of alexithymia on both the physical and the psychosocial
components of the health-related quality of life (HRQoL) of FM
patients, controlling for the concomitant effects of depression,
anxiety, and pain. In particular, given the strong interconnection
between depression and alexithymia, the relationship between
alexithymia and HRQoL as mediated by depressive symptoms
was further investigated. We hypothesized that the presence of
alexithymic trait could negatively influence the impact that FM
symptoms had on patients’ daily quality of life, both directly and
indirectly.
MATERIALS AND METHODS
Study Design
This prospective study was carried out on a consecutive series of
FM patients recruited during their first visit at the Fibromyalgia
Unit of the “A.O.U. Città della Salute e della Scienza – presidio
Molinette” Hospital of Turin. The “A.O.U. Citta della Salute
e della Scienza – A.O. Ordine Mauriziano of Turin – A.S.L.
TO1 Ethic Committee” approved the study (“Psy-FM-AR Study,”
procedure number CS/506) and all patients provided their
written informed consent.
Subjects and Procedure
At the end of their first visit at the Fibromyalgia Unit, all
the female patients with a main diagnosis of FM, made by
an expert rheumatologist, and fulfilling the inclusion/exclusion
criteria were invited to participate. The main exclusion criteria
were: less than 18 years old; low educational level (<5 years) or
insufficient knowledge of the Italian language; unstable medical
or psychiatric illness or current primary psychiatric diagnosis
including severe depression; pain due to traumatic injury or
structural/regional rheumatic disease. Out of the 354 consecutive
FM patients contacted, 35 refused to participate in the study
and 114 were excluded according to the exclusion criteria.
A total of 205 patients composed the final sample. Recruited
patients arranged an appointment with a trained doctoral
clinical psychology student that assessed socio-demographic and
clinical characteristics, and administered the pencil-and-paper
psychological scales. The appointment lasted approximately
45 min.
Variables and Instruments
Pain Characteristics
The pain intensity (PI) was measured using a Visual Analog
Scale (VAS) and the Italian Pain Questionnaire (IPQ). Regarding
the VAS, patients were asked to rate the average intensity of
pain experienced in the last week on a scale ranging from 0
(No pain) to 10 (Extreme pain). In the IPQ (De Benedittis
et al., 1988), a reconstructed Italian version of the McGill
Pain Questionnaire, patients had to choose from 42 adjectives
those that best described their pain. According to the model
of Melzack and Torgerson (1971), the pain descriptors are
divided into three main domains: sensory (IPQ-S), that measures
modality and temporospatial qualities of pain, e.g., “stabbing,”
“pulsing”; affective (IPQ-A), that measures tension, fear, and
autonomic components of the pain experience, e.g., “nauseating,”
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“distressing”; and evaluative (IPQ-E) that measures the subjective
intensity of the global pain experiences, e.g., “intolerable,”
“annoying.” The sum scores of each of the dimensions of pain
were reported as a portion (0–1) of the maximum possible score
of each subscale.
Alexithymia
Alexithymia was assessed using the Italian version of the 20-Item
Toronto Alexithymia Scale (TAS-20) (Bressi et al., 1996; Taylor
and Bagby, 2004). The TAS-20 is composed by 20 items rated
on a five-point Likert scale, from “strongly disagree” to “strongly
agree.” In addition to the total score, the TAS-20 provides three
subscale scores: “Difficulty identifying feelings” (DIF); “Difficulty
describing feeling” (DDF); and “Externally oriented thinking
scale” (EOT). According to the literature (Taylor et al., 1999),
cut-off points were used to divide patients into non-alexithymic
(total score≤ 51), borderline (total score between 51 and 61), and
alexithymic (total score ≥ 61).
Psychological Distress
The Italian version of the Hospital Anxiety and Depression Scale
(HADS) (Costantini et al., 1999; Bjelland et al., 2002) was used
to evaluate the presence of depressive and anxiety symptoms. It
consists of 14 items divided into two subscales (range score: from
0 to 21): HADS-D for the depressive and HADS-A for the anxiety
symptoms. A score of 8 or more suggests a clinically relevant level
of depression/anxiety symptoms (Zigmond and Snaith, 1983).
Health-Related Quality of Life (HRQoL)
The Italian version of the Short-Form 36 Health Survey (SF-
36) was used (McHorney et al., 1993; Apolone and Mosconi,
1998). It consists of 36 items divided into 8 subscales, which
could be gathered into two main components: the Physical
Component (SF-36_PC) composed by the Physical Functioning
(PF), Physical Role Functioning (RP), Bodily Pain (BP), and
General Health (GH) subscales; and the Mental Component (SF-
36_MC) composed by the Vitality (VT), Social Functioning (SF),
Emotional Role Functioning (RE), and Mental Health (MH)
subscales. The scores range from 0 to 100, with the highest scores
corresponding to the better condition.
Statistical Analyses
Normal distribution was assessed following the criteria of
absolute skewness (Sk) and kurtosis (K) values lower than 3.0
and 8.0, respectively (Kline, 2005). Based on these criteria, the
assumption of normality was met for all the variables. Mean
(SD) scores and frequencies were used as descriptive analyses, as
appropriate. Pearson’s bivariate correlations were used to analyze
the relationship between demographic, clinical and psychological
variables, and HRQoL.
Two hierarchical multiple regression analyses were used to
investigate whether alexithymia was a significant contributing
factor for the explanation of the HRQoL in FM patients,
using the Physical and Mental Components scores of the
SF-36 as outcome variables. Stepwise method was used for
variables inclusion of potentially confounding and competing
predictors. To avoid unnecessary reductions in statistical
power, confounding (age and educational level) and competing
(depressive and anxiety symptoms, pain duration, and PI)
predictors’ variables were included in the regression models
only when they were significantly correlated with the outcome
variables (p-value < 0.05). Collinearity was assessed using the
statistical factors of tolerance and Variance Inflation Factor (VIF).
Lastly, a mediation analysis was conducted to test the
mediating effect of depression on the association between
alexithymia and patient’s HRQoL. As recommended by Preacher
and Hayes (2004, 2008), mediation analysis procedures with
bootstrap sampling were performed. The bootstrap method
estimates indirect effects through one or more mediator
variables with bias-corrected bootstrap confidence intervals (CIs)
(Preacher and Hayes, 2004, 2008). A total of 1000 bootstrap
resamples were used to generate bias-corrected 95% CIs for the
indirect effect. Mediation is demonstrated when the indirect
effect is significant and the CIs do not contain zero (Preacher and
Hayes, 2004, 2008).
All the analyses were performed with the software “Statistical
Package for Social Sciences – version 22” (SPSS-22). The
mediation analyses were conducted using the PROCESS macro
(Hayes, 2013), a computational procedure for SPSS.
RESULTS
Data on the socio-demographic and pain variables are reported
in Table 1. Patients had a mean (SD) age of 51 (10) years and
the majority of them had a secondary school degree at least. On
average, the patients had chronic pain from 8 years and the mean
PI was higher than 7. The result of the IPQ showed that patients
reported the highest scores in the affective pain dimension
(IPQ-A).
Data regarding alexithymia and psychological distress are
presented in Table 2. A total of 26% of the sample reported the
presence of alexithymic trait at a clinical level (53 patients) and
another 26% showed this trait at a subclinical level (54 patients).
More than 60% of the patients reported a clinically relevant level
of depressive/anxiety symptoms.
Data regarding the HRQoL are summarized in Table 2.
Patients reported very low mean values in all the subscales of the
SF-36, suggesting the presence of a poor QoL in both its physical
and mental components.
Correlational Analyses
In order to verify possible relationships between clinical and
psychological variables, and HRQoL, correlation analyses were
performed (Table 3). Age, educational level, and pain duration
were not significantly correlated with the physical and mental
components of the SF-36. Pain was negatively and significantly
correlated with both the SF-36_PC (p < 0.001) and the SF-
36_MC (p < 0.001): the higher the PI, the lower the HRQoL.
Statistically significant negative correlations were found between
HADS-D and HADS-A, and both the physical and the mental
components of the SF-36 (all p < 0.001), showing that higher
psychological distress symptoms were correlated with a worse
HRQoL. Regarding alexithymia, the DIF and DDF subscales
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TABLE 1 | Socio-demographic and clinical variables of the 205 patients.
N (%) Mean (SD) Range
Age 51.84 (10.3) 24–74
Educational level (years) 10.78 (3.3) 5–18
Primary School 14 (6.9)
Secondary School 83 (41.1)
Higher School 90 (44.6)
University 15 (7.4)
Marital status
Single 16 (7.9)
Living together 14 (6.9)
Married 138 (68)
Divorced 26 (12.8)
Widowed 9 (4.4)
Work status
Student 1 (0.5)
Employed 116 (57.7)
Unemployed 14 (7)
Retired 32 (15.9)
Housewife 38 (18.9)
Pain variables
Pain duration (months) 102.11 (83.9) 4–420
Pain intensity (VAS) 7.24 (2.4) 0–10
IPQ 28.23 (13.4) 2–74
IPQ-S 0.35 (0.15) 0–0.91
IPQ-A 0.39 (0.21) 0–1
IPQ-E 0.31 (0.21) 0–1
IPQ (159 patients): Italian Pain Questionnaire; IPQ-S: Italian Pain Questionnaire-
Sensory; IPQ-A: Italian Pain Questionnaire-Affective; IPQ-E: Italian Pain
Questionnaire-Evaluative.
of the TAS-20 were significantly correlated with both the SF-
36_PC (DIF: p < 0.001; DDF: p = 0.006) and the SF-36_MC
(both p < 0.001), suggesting that higher difficulty identifying
and describing feelings were associated with a worse HRQoL. No
significant correlations emerged between HRQoL and the EOT
subscale of the TAS-20.
Higher alexithymia scores were also significantly correlated
with higher scores on the HADS-D (DIF: p < 0.001; DDF:
p < 0.001; EOT: p = 0.016) and the HADS-A (DIF: p < 0.001;
DDF: p < 0.001; EOT: p = 0.021) scales, suggesting that higher
level of alexithymia were associated with a higher psychological
distress. Both alexithymia (DIF: p < 0.001; DDF: p = 0.001) and
psychological distress (HADS-D: p< 0.001; HADS-A: p< 0.001)
were significantly correlated with the VAS score: the higher
the PI, the higher the alexithymia and psychological distress
symptoms.
Regression Analyses
Two hierarchical multiple regression analyses were performed
in order to investigate whether alexithymia was a significant
predictor of both the physical and the mental components of
HRQoL in FM patients. The variables age, educational level,
pain duration, and the EOT subscale of the TAS-20 were no
longer included in the regression analyses since they showed
no significant correlation with the criterions. The DIF and the
TABLE 2 | Alexithymia, psychological distress, and health-related quality of life
assessed with the Short-Form 36 Health Survey (SF-36).
Mean (SD) Range N (%)
TAS-20 52.06 (13.2)
Non alexithymic (score < 52) 95 (47)
Borderline (score 52–60) 54 (26.7)
Alexithymic (score > 60) 53 (26.2)
DIF 20.45 (7.3)
DDF 13.71 (4.9)
EOT 17.9 (4.9)
HADS 18.47 (8.1)
HADS-D 9.18 (4.3) 125 (61.3)#
HADS-A 9.29 (4.6) 122 (59.8)#
SF-36
Physical Component 32.4 (15.7) 2.5–83.4
Physical Functioning 47.8 (21.4) 0–100
Physical Role Functioning 17.3 (27.1) 0–100
Bodily Pain 30.4 (16.8) 0–93.3
General Health 34.3 (18.9) 0–90
Mental Component 39.6 (20.4) 6–94.3
Vitality 29.8 (17.5) 0–85
Social Functioning 43.1 (22.2) 0–100
Emotional Role Functioning 35 (39.7) 0–100
Mental Health 50.6 (20.4) 0–96
TAS-20: Toronto Alexithymia Scale – total score; DIF: difficulty identifying feelings;
DDF: difficulty describing feeling; EOT: externally oriented thinking scale; HADS-D/-
A: Hospital Anxiety and Depression Scale-Depression/-Anxiety subscale; SF-36:
Short-Form 36 Health Survey. #Number (%) of patients with a score above
the cut-off (score ≥ 8), suggesting the presence of a clinically relevant level of
depressive/anxiety symptoms.
DDF subscales of the TAS-20 were, therefore, entered in the
first regression block and the competing predictors [depression,
anxiety, and PI (VAS)] were entered in the second block with the
stepwise method.
The regression analysis regarding the Physical Component is
reported in Table 4. In the first model, when only alexithymia
features were entered into the analysis, the difficulty identifying
feeling (DIF) subscale of the TAS-20 significantly predicted the
criterion [β = −0.36, t(196) = −4.31, p < 0.001]. However,
alexithymia ceased to be a predictive factor when depression was
entered into the analysis, in the third model. The final model
(model 3) explained a significant amount (45%) of the variance of
the SF-36_PC [F(4,194) = 41.7, p < 0.001] and PI appeared to be
the strongest contributor [β =−0.46, t(194) =−8.25, p < 0.001],
followed by depression [β =−0.35, t(194) =−5.44, p < 0.001].
The regression analysis regarding the Mental Component
is reported in Table 5. When only alexithymia features were
entered into the analysis (model 1), the difficulty identifying
feeling (DIF) subscale of the TAS-20 significantly predicted
the criterion [β = −0.57, t(196) = −8.09, p < 0.001], with
a 36% of the variance of the SF-36_MC explained. However,
differently from the previous regression, alexithymia continued
to be a predictive factor when competing predictors were
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TABLE 3 | Pearson’s correlations among socio-demographic, clinical, psychological distress, alexithymia, and quality of life assessed with the Short-Form 36 Health
Survey (SF-36).
1 2 3 4 5 6 7 8 9
1 – Age –
2 – Educational level −0.218∗∗ –
3 – Pain Duration 0.255∗∗ −0.018 –
4 – VAS −0.08 0.028 0.077 –
5 – HADS-D −0.012 −0.047 0.123 0.328∗∗ –
6 – HADS-A −0.059 −0.019 0.137 0.362∗∗ 0.678∗∗ –
7 – TAS-20_DIF −0.016 0.008 0.054 0.255∗∗ 0.526∗∗ 0.627∗∗ –
8 – TAS-20_DDF 0.097 −0.129 0.172∗ 0.231∗∗ 0.401∗∗ 0.463∗∗ 0.582∗∗ –
9 – TAS-20_EOT 0.106 −0.318∗∗ 0.058 0.051 0.170∗ 0.162∗ 0.202∗∗ 0.337∗∗ –
10 – SF-36_PC 0.03 0.004 −0.126 −0.575∗∗ −0.505∗∗ −0.420∗∗ −0.341∗∗ −0.194∗∗ −0.012
11 – SF-36_MC 0.058 −0.072 −0.042 −0.483∗∗ −0.652∗∗ −0.697∗∗ −0.600∗∗ −0.390∗∗ −0.084
VAS: Visual Analog Scale for pain intensity; HADS-D/-A: Hospital Anxiety and Depression Scale-Depression/-Anxiety subscale; TAS-20_DIF/_DDF/_EOT: Toronto
Alexithymia Scale_Difficulty identifying feelings/Difficulty describing feeling/Externally oriented thinking subscale; SF-36_PC/_MC: Short-Form 36 Health Survey_Physical
Component/Mental Component. ∗p-value < 0.05; ∗∗p-value < 0.01.
TABLE 4 | Hierarchical multiple regression with Physical Component of Health-related Quality of life (SF-36_PC) as dependent variable (N = 199).
Predictor R2 Adj-R2 F F-1R2 B SE B β p
1 0.12 0.11 13.38∗ 13.38∗
Constant 47.43 3.48
DIF −0.78 0.18 −0.36 <0.001
DDF 0.07 0.27 0.02 0.801
2 0.38 0.37 39.96∗ 82.05∗
Constant 66.09 3.58
DIF −0.54 0.15 −0.25 0.001
DDF 0.24 0.23 0.07 0.299
VAS −3.29 0.35 −0.53 <0.001
3 0.46 0.45 41.74∗ 29.54∗
Constant 66.75 3.35
DIF −0.24 0.16 −0.11 0.129
DDF 0.36 0.21 0.11 0.095
VAS −3.12 0.38 −0.46 <0.001
HADS-D −1.30 0.24 −0.35 <0.001
∗p-value < 0.001. DIF: difficulty identifying feelings; DDF: difficulty describing feelings; HADS-D: Hospital Anxiety and Depression Scale-Depression; VAS: pain intensity.
entered into the analysis. The final model (model 4) explained
a significant portion (61%) of the variance of the SF-36_MC
[F(5,193) = 62.9, p < 0.001]. Anxiety symptoms [HADS-A:
β = −0.30, t(193) = −4.39, p < 0.001], depressive symptoms
[HADS-D: β =−0.25, t(193) =−4.13, p< 0.001] and alexithymia
[DIF: β = −0.25, t(193) = −3.84, p < 0.001] followed by PI
[VAS: β =−0.24, t(193) =−4.99, p < 0.001] were the factors that
significantly predicted the SF-36_MC score.
Mediation Analysis
To deepen the results of the multiple regression analyses, a
mediation analysis was conducted to test the relationship between
alexithymia and the patients’ HRQoL mediated by depressive
symptoms. On the basis of the results of the regression analyses,
the DIF subscale was used.
Regarding the Physical component (Figure 1A), the
standardized regression coefficient between DIF and depressive
symptoms was statistically significant (p < 0.001), as was the
standardized regression coefficient between depressive symptoms
and SF-36_PC (p < 0.001). The standardized indirect effect was
(0.52)(−0.46) = −0.24. We tested the significance of this
indirect effect using bootstrapping procedures. The bootstrapped
unstandardized indirect effect was−0.52, and the 95% CI ranged
from −0.73 to −0.35. Thus, the results confirm that, even if
DIF did not have a direct effect on the SF-36_PC (standardized
regression coefficient = −0.11, p = 0.13), it had a significant
indirect effect (κ2 = 0.22) through depressive symptoms.
Concerning the Mental Component (Figure 1B), the
standardized regression coefficient between depressive symptoms
and SF-36_MC was statistically significant (p < 0.001). The
standardized indirect effect was (0.52)(−0.46) = −0.24. The
bootstrapped unstandardized indirect effect was −0.66, and
the 95% CI ranged from −0.90 to −0.48. Thus, in addition
to confirm the presence of a statistically significant direct
effect (standardized regression coefficient = −0.37, p < 0.001),
the results confirm that the difficulty identifying feeling
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TABLE 5 | Hierarchical multiple regression with Mental Component of Quality of life (SF-36_MC) as dependent variable (N = 198).
Predictor R2 Adj-R2 F F-1R2 B SE B β p
1 0.37 0.36 56.45∗ 56.45∗
Constant 75.22 3.80 <0.001
DIF −1.60 0.20 −0.57 <0.001
DDF −0.22 0.29 −0.05 0.457
2 0.53 0.52 72.80∗ 67.31∗
Constant 76.38 3.29 <0.001
DIF −0.80 0.20 −0.29 <0.001
DDF 0.07 0.26 0.02 0.788
HADS-A −2.31 0.28 −0.52 <0.001
3 0.59 0.58 68.74∗ 27.22∗
Constant 87.96 3.81 <0.001
DIF −0.78 0.19 −0.28 <0.001
DDF 0.13 0.24 0.03 0.600
HADS-A −1.92 0.28 −0.43 <0.001
VAS −2.25 0.43 −0.26 <0.001
4 0.62 0.61 62.95∗ 17.03∗
Constant 89.62 3.68 <0.001
DIF −0.69 0.18 −0.25 <0.001
DDF 0.18 0.23 0.04 0.444
HADS-A −1.32 0.30 −0.30 <0.001
VAS −2.08 0.42 −0.24 <0.001
HADS-D −1.22 0.30 −0.25 <0.001
∗p-value < 0.001. DIF: difficulty identifying feelings; DDF: difficulty describing feelings; HADS-D/-A: Hospital Anxiety and Depression Scale-Depression/Anxiety; DT:
Distress Thermometer; VAS: pain intensity.
FIGURE 1 | Standardized regression coefficients for the relationship between
alexithymia and the Physical (A) and Mental (B) components of the SF-36 as
mediated by depressive symptoms. The standardized regression coefficients
between the difficulty identifying feeling (DIF) subscales of the TAS-20 and
HRQoL, controlling for depressive symptoms, are in parentheses. ∗p < 0.001.
subcomponent of alexithymia had a significant indirect effect
on the Mental Component of the SF-36 (κ2 = 0.25) through
depressive symptoms.
DISCUSSION
The present study evaluated the effects of alexithymia in
a large sample of patients with FM, controlling for the
concomitant effects of depression, anxiety, and pain. To deepen
the investigation of the specific impact that alexithymia has
on both the physical and the psychosocial components of the
HRQoL, we also evaluated the mediation role of depressive
symptoms. In fact, even though FM does not cause physical
injuries or deformed joints, it causes a severe disability in
daily living, negatively interfering with the patient’s functional,
working, and psychosocial capacity (Sturge-Jacobs, 2002; Arnold
et al., 2008). Available data underline that the negative impact on
the quality of life may be even greater than those experienced
in other chronic pain disorders and rheumatic conditions
(Martinez et al., 1995; Bergman, 2005; Boonen et al., 2005;
Birtane et al., 2007; Ubago Linares Mdel et al., 2008; White
et al., 2008; Sicras-Mainar et al., 2009). In the current study,
the results confirmed the great impact of the pathology on the
patients’ quality of life, on both the physical and the mental
components, with very low score in all the subscales of the
SF-36.
Depressive disorders are the most frequent comorbid
psychiatric conditions in FM with a prevalence of 20–80% (Fietta
et al., 2007). In a community sample of 44,897 individuals, Kato
et al. (2006) showed that 40% of patients with FM had current
depressive symptoms without a formal diagnosis of depressive
disorder whereas the rate of lifetime major depressive disorder
comorbidity ranges from 62 to 86% (Aguglia et al., 2011). In line
with these data, in the current study, the mean scores of both the
depression and the anxiety subscales of the HADS were above
the threshold, suggesting an extensive prevalence of clinically
relevant depressive and anxiety symptoms, both present in about
60% of patients.
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Up to date, studies evaluating the prevalence and the role of
alexithymia in FM patients showed contrasting results (Di Tella
and Castelli, 2013). Most studies agree on the higher prevalence
of alexithymia in FM compared to healthy controls or to patients
with other chronic pain pathologies such as rheumatoid arthritis
(Sayar et al., 2004; Huber et al., 2009; Steinweg et al., 2011; Tuzer
et al., 2011). The estimated prevalence of alexithymia in non-
clinical samples ranges between 7 and 13% (Fukunishi et al., 1999;
Mattila et al., 2006; Honkalampi et al., 2009), whereas according
to the most recent reviews of the literature, the prevalence of
alexithymia in patients with FM ranges from 15 to 20% (Di
Tella and Castelli, 2013). Conforming to these data, 26% of
the patients with FM recruited in the present study showed
the presence of alexithymia and another 26% had a TAS-20
total score in the borderline range, suggesting the presence of
a subclinical level of alexithymic traits. Some studies consider
the high prevalence of alexithymia in FM as related to the
concomitant high prevalence of depressive symptoms (Malt et al.,
2002; Evren et al., 2006; Huber et al., 2009). Clinical researches
conducted in various clinical settings have indeed shown a high
incidence of alexithymia in patients with depression, which
varies between 21 and 42% (Saarijärvi et al., 1993; Wise and
Mann, 1995; Honkalampi et al., 2000, 2001; Taycan et al.,
2017). Since both constructs share many characteristics, such
as negative affect, decreased ability to communicate affect to
other people, problems with interpersonal communication and
less clarity about own feelings, it is reasonable to assume that
there is an association between alexithymia and depression (Rude
and McCarthy, 2003; Mattila et al., 2008; Picardi et al., 2011).
Moreover, some researchers found that the decrease of the level
of depression is associated with a TAS-20 scores decrease in
patients with major depression, suggesting that alexithymia could
be considered as a state-dependent phenomenon in people with
depression (Honkalampi et al., 2000, 2001; Saarijärvi et al.,
2001). Regarding chronic pain patients, previous studies, which
evaluated alexithymia and depression in large heterogeneous
chronic pain samples, suggested that depression worked as a
full mediator between alexithymia and daily disability in FM
(Makino et al., 2013; Saariaho et al., 2013; Shibata et al., 2014).
Also the results of our previous exploratory study appeared to
support this hypothesis (Castelli et al., 2012). In that study,
even if the small sample size cautioned to interpret and
generalize the data, the results seem to point out that the
relationship between alexithymia and quality of life in FM could
be totally mediated by the presence of psychological distress
symptoms. In fact, alexithymia ceased to significantly contribute
to the explanation of HRQoL when the psychological distress
variables (depression for the physical component and anxiety
for the mental component of HRQoL) were added as competing
predictors (Castelli et al., 2012).
Given the exploratory nature and the small sample size of
our previous study (Castelli et al., 2012), we performed a new
study on a larger sample. The results of this last study confirmed
the previous ones regarding the physical component of HRQoL.
As in our previous work, alexithymia, in particular the difficulty
identifying feeling subscale, ceased to significantly contribute to
the explanation of the SF-36_PC when the depressive symptoms
were added as competing predictor. PI and depression were the
variables that significantly contributed to explain the variance
of the SF-36_PC, with a good final model that explained 45%
of the variance. Although PI and pain persistence in FM are
independent from a coexisting depression or a concomitant
psychological distress (Okifuji et al., 2000; Petzke et al., 2003),
our results seem to suggest that these variables have a similar and
additive effect in negatively influencing the physical functioning
of FM patients, further supporting the multidimensionality
nature of this pathology.
Regarding the psychosocial functioning, the results of the
present study allowed us to go further with the results of our
previous work (Castelli et al., 2012). Indeed, in the hierarchical
multiple regression analysis performed on the mental component
of HRQoL, alexithymia significantly contributed to the model
even when controlling for the presence of psychological distress.
Pain, anxiety and depressive symptoms, and the DIF subscale of
the TAS-20 were all significant predictors of the SF-36_MC, with
a final model explaining a very high percentage of the variance
(61%).
This last result suggests that alexithymia has a significant
direct effect on the psychosocial functioning of patients with
FM. To better evaluate the weight of this effect on the mental
component of the SF-36, and the presence of an indirect
effect, mediated by depressive symptoms, on both the mental
and the physical components, we performed the mediation
analyses. The results further supported those of the regression
model, confirming the presence of a significant direct effect of
alexithymia on the mental component of the SF-36. These data
provide methodologically grounded support to the hypothesis
that the presence of alexithymia per se had a negative impact
on FM patients’ HRQoL. Furthermore, the results showed that
the DIF factor of the TAS-20 had a significant indirect effect
on both the components of the HRQoL, mediated by depressive
symptoms. The data showed, in fact, that the presence of difficulty
identifying feelings had an important negative effect on the
presence of depressive symptoms, which in turn negatively affects
patients’ HRQoL. As showed by the κ2 value, the effect size of
the indirect effect was medium for the physical component and
large for the mental one. Taken together, these findings suggest
that the patient difficulty identifying emotions may, on one hand,
have an indirect effect, increasing symptoms of depression, which
in turn may interfere with the individual’s ability to deal or
cope with pain. On the other hand, the difficulty identifying
emotions may also be considered a trait that directly influences
illness behavior, as hypothesized by Lumley (Lumley et al., 1996).
According to his model, the higher body awareness of individuals
with alexithymia makes them focus on benign somatic sensations,
thereby increasing sensation magnitude through a positive,
autonomic feedback loop. As a result of the inability to identify
accurately their own subjective feelings, they attribute these
sensations to biological causes rather than psychological ones,
thus experiencing these sensations as physical illness instead of
the somatic manifestation of their own emotions (Lumley et al.,
1996).
Such contrasting results regarding the relationship between
alexithymia and depression in chronic pain could partially be
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the result of the negligence of the distinction between absolute
and relative stability. Indeed, even if alexithymia lacks of absolute
stability (i.e., its score may change in the presence of large
changes in the severity of depressive symptoms), its relative
stability has been demonstrated not only in patients with major
depression, but also in patients with functional gastrointestinal
disorders (Luminet et al., 2001; Porcelli et al., 2003; Taylor and
Bagby, 2004). It can be argued that the lack of absolute stability
of alexithymia could lead to attribute the high prevalence of
alexithymia in FM only to the concomitant high prevalence of
depressive symptoms, masking its direct effect in chronic pain
patients, independently from the depressive symptoms.
Some main limitations have to be taken into account
while considering the present study. Only female patients
were evaluated and we did not include any control groups.
Further studies comparing FM to other chronic pain pathologies
should therefore be carried out. What is more, while this
study contributes with important information regarding how
alexithymia and depression may interact in FM, the cross-
sectional nature of the study does not allow proving causal
relationships. Future researches should address emotional deficits
in this chronic pain pathology through longitudinal studies,
assessing the variation of these co-occurring symptoms along the
disease progression.
CONCLUSION
The results of the present study suggest the presence of both
a direct and an indirect effect of alexithymia on the HRQoL
in patients with FM. Indeed, even though the concomitant
presence of depressive symptoms is responsible of an indirect
effect, alexithymia per se seems to directly contribute to worsen
the impact that this chronic pain pathology has on the patients’
quality of life, especially regarding the psychosocial functioning.
Taken together these results have an important implication for
the treatment of FM patients. As recently reported, indeed,
treatment strategies have on average only modest results in
FM patients, calling for a more individualized management
strategy (Castelnuovo et al., 2016a,b; Häuser et al., 2017). The
presence of a direct and an indirect effect of alexithymia in FM,
mediated by depressive symptoms, together with the evidence
supporting the predictive role of alexithymia on the treatment
outcome (Taylor and Bagby, 2004), further support the need
for a multidimensional approach that includes its assessment.
Even though there is an absence of established efficacious
treatments for alexithymia, a recent review provides a strong
case for the partial modifiability of alexithymia, but only by
means of psychological interventions specifically intended to
treat it (Cameron et al., 2014). According to the available
research data, indeed, some aspects of alexithymia, as those
of other dimensional personality traits, such as neuroticism
or extraversion, may be more trait-like and thus enduring,
whereas other aspects may be more state-dependent and thus
changeable (Cameron et al., 2014). Furthermore, available
research data suggest that identifying effective strategies for
modifying alexithymia not only improves patients’ adaptive
emotional processing, but also enhances other aspects of
functioning (Cameron et al., 2014). Similar results were found in
two very recent studies that evaluated the efficacy of an emotional
awareness and expression therapy in chronic pain patients,
including FM, which found that the decrease in alexithymia was
linked to the improvements in PI and pain interference (Burger
et al., 2016; Lumley et al., 2017). These data underline once again
the importance to evaluate the presence of alexithymia in FM
patients, in order to identify a patient-tailored therapy, aiming at
optimizing treatment efficacy, and at minimizing costs and risks
due to the use of ineffective therapies.
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